Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad H Alshaer

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Intensive Care Medicine|March 1, 2022
Another trial for the TARGET trialMohammad H Alshaer, Charles A Peloquin
Pulmonary Pharmacology & Therapeutics|November 26, 2023
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patientsLily Zheng, Mohammad H Alshaer, Charles Peloquin, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative InfectionsNicole F Maranchick, Jessica Webber, Mohammad H Alshaer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 20, 2023
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignanciesEmma F Lodl, Mohammad H Alshaer, C Brooke Adams, et al.
Respiratory Medicine|April 8, 2023
Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung functionJason Brandon Katz, Purav Shah, Cesar A Trillo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 15, 2022
Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical centerVeena Venugopalan, Malva Hamza, Barbara Santevecchi, et al.
Journal of the International Association of Providers of AIDS Care|August 26, 2022
Effect of Rifabutin in Dolutegravir Dosing: A Case SeriesMaria A Mendoza, Mohammad H Alshaer, Giovanni Roldan, et al.
Therapeutic Drug Monitoring|November 29, 2023
A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe PneumoniaNicole F Maranchick, Cesar Trillo-Alvarez, Vidhu Kariyawasam, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2023
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adultsJack Chang, Jiajun Liu, Mohammad H Alshaer, et al.
International Journal of Antimicrobial Agents|January 16, 2023
Beta-lactam target attainment and associated outcomes in patients with bloodstream infectionsMohammad H Alshaer, Nicole Maranchick, Kaitlin M Alexander, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Intensive Care Medicine|March 1, 2022
Another trial for the TARGET trialMohammad H Alshaer, Charles A Peloquin
Pulmonary Pharmacology & Therapeutics|November 26, 2023
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patientsLily Zheng, Mohammad H Alshaer, Charles Peloquin, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative InfectionsNicole F Maranchick, Jessica Webber, Mohammad H Alshaer, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 20, 2023
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignanciesEmma F Lodl, Mohammad H Alshaer, C Brooke Adams, et al.
Respiratory Medicine|April 8, 2023
Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung functionJason Brandon Katz, Purav Shah, Cesar A Trillo, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 15, 2022
Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical centerVeena Venugopalan, Malva Hamza, Barbara Santevecchi, et al.
Journal of the International Association of Providers of AIDS Care|August 26, 2022
Effect of Rifabutin in Dolutegravir Dosing: A Case SeriesMaria A Mendoza, Mohammad H Alshaer, Giovanni Roldan, et al.
Therapeutic Drug Monitoring|November 29, 2023
A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe PneumoniaNicole F Maranchick, Cesar Trillo-Alvarez, Vidhu Kariyawasam, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2023
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adultsJack Chang, Jiajun Liu, Mohammad H Alshaer, et al.
International Journal of Antimicrobial Agents|January 16, 2023
Beta-lactam target attainment and associated outcomes in patients with bloodstream infectionsMohammad H Alshaer, Nicole Maranchick, Kaitlin M Alexander, et al.
Pageof 3